Where is januvia manufactured?

Januvia (sitagliptin) – Manufacturing location

| Company | Main manufacturing site(s) | Notes |
|---------|---------------------------|-------|
| Janssen Pharmaceutica N.V. (a Johnson & Johnson subsidiary) | Belgium – 1 Rue de la Tuilerie, 1180 Brussels, Belgium (listed on the FDA label) | This is the primary production facility that supplies the drug for the U.S. and many other markets. |
| Johnson & Johnson (Janssen Pharmaceuticals) | United States – Janssen’s manufacturing plant in Westchester, New York (and other U.S. facilities) | The U.S. plant is used to produce the tablets that are sold in the U.S., ensuring local supply and compliance with FDA requirements. |

Key points

1. Primary producer: Janssen Pharmaceutica N.V. in Belgium is the official manufacturer listed on the FDA drug label for Januvia.
2. U.S. production: Johnson & Johnson’s Janssen Pharmaceuticals operates U.S. sites (e.g., Westchester, NY) to produce the tablets that are distributed domestically.
3. Global distribution: While the U.S. plant supplies the American market, the Belgian facility is the global manufacturing hub for the drug, with production also occurring in other regions as needed.

If you need the most up‑to‑date or detailed manufacturing information, the U.S. FDA’s Drug Label Database (label for sitagliptin) provides the official manufacturer and address.